Plant Comparison
Flaxseed vs Dog-rose
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Flaxseed and Dog-rose: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Flaxseed | Dog-rose | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 3/10 | 10/10 | Stronger for Dog-rose |
| Cancer (anticancer research) | 7/10 | 2/10 | Stronger for Flaxseed |
| Inflammation (general) | 3/10 | 8/10 | Stronger for Dog-rose |
| Metabolic support | 6/10 | 7/10 | Comparable evidence |
| Skin irritation | 3/10 | 7/10 | Stronger for Dog-rose |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Flax is the richest dietary source of SDG-type lignans, converted by gut bacteria to the mammalian lignans enterodiol and enterolactone; studied for antioxidant and hormone-modulating activity.
The dominant fatty acid of the seed oil (~50-55% of total oil), a plant-based omega-3 studied for cardiovascular and anti-inflammatory effects.
Concentrated in the seed coat; gives flaxseed its demulcent, laxative, bulk-forming action.
Present at low levels; cooking/roasting reduces them to negligible amounts in normal food use - a theoretical concern only at high raw intakes.
The hip is exceptionally rich in vitamin C and carotenoids, underpinning its traditional tonic use. Quantified in commercial dried fruit at beta-carotene 7.25 mg/100 g and lycopene 2.34 mg/100 g fresh weight.
A specific galactolipid fraction studied as the likely active anti-inflammatory constituent in osteoarthritis trials of standardised rosehip powder.
Contribute to antioxidant activity. Leaves carry a higher total phenolic, flavonoid and phenolic-acid content than the hips, and leaf infusions were the only preparation to show antibacterial activity in vitro.
Cold-pressed rose hip seed oil is high in linolenic acid, with phytosterols up to 6485 mg/kg, tocopherols up to 1125 mg/kg and carotenoids up to 108 mg/kg; p-coumaric acid methyl ester predominates among its phenolics.
Pharmacological Actions
In vitro, the lipophilic (n-hexane and dichloromethane) rose hip extracts inhibited COX-1, COX-2 and 5-LOX-mediated leukotriene B4 formation; the aqueous and methanol extracts were inactive.
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from digestive action
inferred from anti-inflammatory action
Two placebo-controlled crossover RCTs of standardised rosehip powder (5 g/day) report reduced WOMAC pain and reduced rescue-medication use in knee/hip osteoarthritis, consistent with the existing meta-analysis.
inferred from anticancer action
Animal evidence only. In high-fat-diet/streptozotocin diabetic rats, R. canina ethanol extract (250 mg/kg) improved recall and long-term memory and reduced hippocampal insulin resistance, amyloid-beta and acetylcholinesterase activity. No human data; the effect is reported in a diabetes model, not in healthy or cognitively impaired people.
inferred from anti-inflammatory action
inferred from anti-inflammatory action
One triple-blind placebo-controlled RCT (n=400) found that 500 mg R. canina fruit capsules twice daily for 20 days after caesarean section reduced the incidence of urinary tract infection. The incidence of cystitis specifically did not differ significantly between groups. Prevention in a post-surgical population; not evidence for treating an established UTI.
Safety, Cautions & Contraindications
Flaxseeds are safe for most people at recommended food amounts (1–2 tablespoons ground/day). They must be ground or milled to be bioavailable — whole seeds largely pass through the gut undigested. High fibre content may cause bloating, flatulence, and loose stools, especially if fibre intake is increased rapidly without adequate hydration. Flaxseeds contain cyanogenic glycosides (linamarin, linustatin); cooking or roasting reduces these to negligible levels in normal food amounts. Raw seeds in very large quantities are a theoretical concern, but typical use is safe (EFSA, 2017).
Medication interactions: Flaxseed may reduce absorption of oral medications if taken simultaneously — space flaxseed supplementation 1–2 hours from medications. Omega-3 ALA and lignans may mildly enhance anticoagulant/antiplatelet effects; use caution with blood thinners. Some sources suggest caution with hormone-sensitive conditions due to phytoestrogen (lignan) content, though dietary amounts are unlikely to pose risk (Adolphe et al., 2010).
Pregnancy: Food amounts are generally considered safe; high-dose supplements should be discussed with a clinician due to limited safety data.
Duke (2002) rates flaxseed as +++ with clinical evidence (score 2) for antiatherogenic, hypocholesterolemic, laxative, lipolytic (fat-dissolving), and demulcent activities. Flaxseed's omega-3 fatty acids (ALA) and lignans are associated with reduced cardiovascular risk. Commission E approves flaxseed as a laxative and for mucilaginous protection of inflamed gastrointestinal mucosa. Dose: 1–2 tablespoons ground seed with ample water, twice daily. Whole seeds should be chewed or ground for full medicinal effect. Cyanogenic glycosides are present but at safe levels in normal dietary amounts (Duke, 2002).
Rosa canina (dog rose) hips are generally recognized as safe (GRAS) for consumption, widely used in teas, jams, and supplements. They are highly nutritious but may cause minor digestive upset (nausea, diarrhea) in some users. The small, irritating hairs around the seeds should be removed before consumption.
Duke (2002) rates dog rose hips as +++ with clinical evidence (score 2) for astringent activity and experimental support for antioxidant and diuretic effects. Dog rose hips are exceptionally rich in vitamin C and bioflavonoids. They are traditionally used for cold and influenza prevention, urinary tract health, and mild diarrhea. Duke notes the diuretic (score 1) and lipoxygenase-inhibitory activities as experimentally documented. The fruit is considered food-grade safe (Duke, 2002).
External Ids
Botanical Description
Erect annual herb, slender and often branched near the top, growing 30-80 (up to 100) cm tall from a fine taproot. Leaves are alternate, sessile, narrowly lanceolate to linear, blue-green and entire-margined. Flowers are pale blue (occasionally white or pink), five-petalled and borne on slender stalks in loose terminal cymes. The fruit is a small globular capsule ('boll') that splits into ten compartments, each containing one flattened, glossy, red-brown seed.[5]
Scrambling, thorny deciduous shrub (Rosaceae), 1-5 m, with arching, prickly stems bearing hooked thorns. Leaves are pinnate with 5-7 oval, toothed leaflets. Pale pink to white, five-petalled flowers are followed by bright red-orange, egg-shaped hips (the fleshy hip is an accessory fruit; the true fruits are small hairy achenes inside it) that ripen in autumn and often persist into winter.[2]
Habitat
Native to the Mediterranean region and the Fertile Crescent, cultivated since prehistory for fibre and oil and now grown worldwide in temperate regions with well-drained, fertile soils and a cool, moist growing season; occasionally found as a naturalised escape on waste and cultivated ground.[5]
Native throughout Europe, north-west Africa and western Asia, common in hedgerows, woodland edges, scrub and roadside verges on a wide range of soils.[2]
Harvesting
Grown as an annual crop, seed is harvested once the capsules ('bolls') have dried and turned brown, typically in late summer, by cutting or combining the whole plant and threshing out the seed. Whole seed stores well; it should only be ground shortly before use, since the oil in ground seed oxidises and turns rancid quickly.[2]
Hips are picked in autumn once fully coloured, then dried for tea or powder, or processed fresh for syrup. The fine, irritant hairs surrounding the seeds inside the hip must be removed before consumption.[5]
Traditional Uses
Flaxseed has a long history of traditional use as a bulk-forming laxative and demulcent for constipation and irritated gut mucosa, and as a poultice for boils and inflamed skin. Modern interest centres on its lignan (secoisolariciresinol diglucoside) and alpha-linolenic acid content, studied for cardiovascular, metabolic and hormone-related outcomes.[2, 4, 5]
Rosehip has a long European folk tradition as a vitamin-C-rich tonic for colds and general immunity, and as a mild diuretic and astringent for urinary and digestive complaints. Modern clinical trials on standardised rosehip powder show a modest, reproducible benefit for osteoarthritis pain and stiffness.[1, 2]
Preparations
Whole seed freshly ground (milled) and taken with plenty of liquid, or stirred into food; grinding is needed to make the oil and lignans bioavailable, as whole seeds largely pass through the gut undigested.
Cold-pressed oil taken as a concentrated source of alpha-linolenic acid (omega-3); lacks the fibre and lignan content of the whole ground seed.
The form used in osteoarthritis clinical trials.
Dosage
Traditional guidance and Duke (2002) suggest 1-2 tablespoons of ground seed with ample water, once or twice daily. Educational reference only, not a prescription.
A randomised placebo-controlled trial titrated flax oil capsules (550 mg alpha-linolenic acid per 1 g of oil) to 12 capsules per day, i.e. up to roughly 12 g of oil daily, over 16 weeks - broadly matching the 1-2 tablespoons (about 10-15 mL) daily often cited for omega-3 intake. That trial was in children and adolescents with bipolar disorder and its primary outcomes were null; it is cited here only as a source for an administered human dose of the oil, not as evidence of benefit. Note the EU herbal monograph on Lini semen covers the SEED, not the oil. Educational reference only, not a prescription.
Clinical trials for osteoarthritis have most often used around 5 g/day of standardised rosehip powder. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Picur, B., Cebrat, M., Zabrocki, J. and Siemion, I.Z (2006) 'Cyclopeptides of Linum usitatissimum', Journal of Peptide Science, 12(9), pp. 569-574. doi:10.1002/psc.779 Preclinical
https://doi.org/10.1002/psc.779 - Basch, E., Bent, S., Collins, J., Dacey, C., Hammerness, P., Harrison, M., Smith, M., Szapary, P., Ulbricht, C., Vora, M. and Weissner, W (2007) 'Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration', Journal of the Society for Integrative Oncology, 5(3), pp. 92-105. doi:10.2310/7200.2007.005 Meta-analysis / review
https://doi.org/10.2310/7200.2007.005 - Chhillar, H., Chopra, P. and Ashfaq, M.A (2020) 'Lignans from linseed (Linum usitatissimum L.) and its allied species: retrospect, introspect and prospect', Critical Reviews in Food Science and Nutrition, 61(16), pp. 2719-2741. doi:10.1080/10408398.2020.1784840 Meta-analysis / review
https://doi.org/10.1080/10408398.2020.1784840 - Ansari, R., Zarshenas, M.M. and Dadbakhsh, A.H (2019) 'A review on pharmacological and clinical aspects of Linum usitatissimum L', Current Drug Discovery Technologies, 16(2), pp. 148-158. doi:10.2174/1570163815666180521101136 Meta-analysis / review
https://doi.org/10.2174/1570163815666180521101136 - Akter, Y., Junaid, M., Afrose, S.S., Nahrin, A., Alam, M.S., Sharmin, T., Akter, R. and Hosen, S.M.Z (2021) 'A comprehensive review on Linum usitatissimum medicinal plant: its phytochemistry, pharmacology, and ethnomedicinal uses', Mini Reviews in Medicinal Chemistry, 21(18), pp. 2801-2834. doi:10.2174/1389557521666210203153436 Meta-analysis / review
https://doi.org/10.2174/1389557521666210203153436 - Musazadeh, V., Abolghasemian, M., Kavyani, Z., Moridpour, A.H., Nazari, A. and Faghfouri, A.H (2024) 'The effects of flaxseed (Linum usitatissimum) supplementation on anthropometric indices: an updated systematic review and meta-analysis of randomized clinical trials', Complementary Therapies in Medicine, 84, pp. 103066. doi:10.1016/j.ctim.2024.103066 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2024.103066 - Mueed, A., Shibli, S., Jahangir, M., Jabbar, S. and Deng, Z (2022) 'A comprehensive review of flaxseed (Linum usitatissimum L.): health-affecting compounds, mechanism of toxicity, detoxification, anticancer and potential risk', Critical Reviews in Food Science and Nutrition, 63(32), pp. 11081-11104. doi:10.1080/10408398.2022.2092718 Meta-analysis / review
https://doi.org/10.1080/10408398.2022.2092718 - Kaithwas, G., Mukherjee, A., Chaurasia, A.K. and Majumdar, D.K (2011) 'Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixed oil', Indian Journal of Experimental Biology, 49(12), pp. 932-938. Preclinical
https://scholar.google.com/scholar?q=Anti-inflammatory%2C%20analgesic%20and%20antipyretic%20activities%20of%20Linum%20usitatissimum%20L.%20%28flaxseed/linseed%29%20fixed%20oil - Rafieian-Kopaei, M., Shakiba, A., Sedighi, M. and Bahmani, M (2017) 'The analgesic and anti-inflammatory activity of Linum usitatissimum in Balb/c mice', Journal of Evidence-Based Complementary & Alternative Medicine, 22(4), pp. 892-896. doi:10.1177/2156587217717416 Preclinical
https://doi.org/10.1177/2156587217717416 - Sirotkin, A.V (2023) 'Influence of flaxseed (Linum usitatissimum) on female reproduction', Planta Medica, 89(6), pp. 608-615. doi:10.1055/a-2013-2966 Meta-analysis / review
https://doi.org/10.1055/a-2013-2966 - Thompson, L.U., Chen, J.M., Li, T., Strasser-Weippl, K. and Goss, P.E (2006) 'Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer', 11(10), pp. 3828--3835. doi:10.1158/1078-0432.CCR-04-2326 Randomized trial
https://doi.org/10.1158/1078-0432.CCR-04-2326 - Adolphe, J.L., Whiting, S.J., Juurlink, B.H.J., Thorpe, L.U. and Alcorn, J (2010) 'Health effects with consumption of the flax lignan secoisolariciresinol diglucoside', 103(7), pp. 929--938. doi:10.1017/S0007114509992753 Clinical study
https://doi.org/10.1017/S0007114509992753 - Caligiuri, S.P.B., Edel, A.L., Aliani, M. and Pierce, G.N (2014) 'Flaxseed for hypertension: implications for improved cardiovascular risk', 16(12), pp. 499. doi:10.1007/s11906-014-0499-8 Randomized trial
https://doi.org/10.1007/s11906-014-0499-8 - European Food Safety Authority (2017) 'Safety of cyanogenic glycosides from flaxseed consumed as part of a usual diet', 15(11). doi:10.2903/j.efsa.2017.5026 Preclinical
https://doi.org/10.2903/j.efsa.2017.5026 - Harris, W.S (2012) 'Stearidonic acid as a surrogate for eicosapentaenoic acid in cardiovascular risk reduction: update and recommendation', 70(10), pp. 565--574. Traditional / reference
https://scholar.google.com/scholar?q=Stearidonic%20acid%20as%20a%20surrogate%20for%20eicosapentaenoic%20acid%20in%20cardiovascular%20risk%20reduction%3A%20update%20and%20recommendation - Latvijas valsts mežzinātnes institūts (n.d.) 'Linsēkla Latvijā'. Available at: https://www.silava.lv Traditional / reference
https://www.silava.lv - Pan, A., Sun, J., Chen, Y. et al (2009) 'Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial', 4(11). doi:10.1371/journal.pone.0007654 Randomized trial
https://doi.org/10.1371/journal.pone.0007654 - Royal Botanic Gardens, Kew (n.d.) 'Linum usitatissimum L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 - Gracious, B.L., Chirieac, M.C., Costescu, S., Finucane, T.L., Youngstrom, E.A. and Hibbeln, J.R (2010) 'Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder', Bipolar Disorders, 12(2), pp. 142-154. doi:10.1111/j.1399-5618.2010.00799.x Randomized trial
https://doi.org/10.1111/j.1399-5618.2010.00799.x - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Christensen, R., Bartels, E.M., Altman, R.D., Astrup, A. and Bliddal, H (2008) 'Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? - a meta-analysis of randomized controlled trials', Osteoarthritis and Cartilage, 16(9), pp. 965-972. doi:10.1016/j.joca.2008.03.001 Meta-analysis / review
https://doi.org/10.1016/j.joca.2008.03.001 - Gruenwald, J., Uebelhack, R. and More, M.I (2019) 'Rosa canina - Rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis - A systematic review', Phytomedicine, 60, pp. 152958. doi:10.1016/j.phymed.2019.152958 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2019.152958 - Sanz-Lamora, H., Nicola-Llorente, M., Torres-Oteros, D., Perez-Marti, A. and others (2024) 'The Antiobesity Effects of Rosehip (Rosa canina) Flesh by Antagonizing the PPAR Gamma Activity in High-Fat Diet-Fed Mice', Molecular Nutrition & Food Research, 68(5), pp. e2300539. doi:10.1002/mnfr.202300539 Preclinical
https://doi.org/10.1002/mnfr.202300539 - Tumbas, V.T., Canadanovic-Brunet, J.M., Cetojevic-Simin, D.D., Cetkovic, G.S. and others (2011) 'Effect of rosehip (Rosa canina L.) phytochemicals on stable free radicals and human cancer cells', Journal of the Science of Food and Agriculture, 92(6), pp. 1273-1281. doi:10.1002/jsfa.4695 Preclinical
https://doi.org/10.1002/jsfa.4695 - Pena, F., Valencia, S., Tereucan, G., Nahuelcura, J. and others (2023) 'Bioactive Compounds and Antioxidant Activity in the Fruit of Rosehip (Rosa canina L. and Rosa rubiginosa L.)', Molecules, 28(8), pp. 3544. doi:10.3390/molecules28083544 Preclinical
https://doi.org/10.3390/molecules28083544 - Hendrysiak, A., Brzezowska, J., Nicolet, N., Bocquel, D. and others (2023) 'Juice Powders from Rosehip (Rosa canina L.): Physical, Chemical, and Antiglycation Properties', Molecules, 28(4), pp. 1674. doi:10.3390/molecules28041674 Preclinical
https://doi.org/10.3390/molecules28041674 - Igual, M., Garcia-Herrera, P., Camara, R.M., Martinez-Monzo, J. and others (2022) 'Bioactive Compounds in Rosehip (Rosa canina) Powder with Encapsulating Agents', Molecules, 27(15), pp. 4737. doi:10.3390/molecules27154737 Preclinical
https://doi.org/10.3390/molecules27154737 - Truong, V.L. and Jeong, W.S (2023) 'Hair Growth-Promoting Effects of Rosehip (Rosa canina L.) Seed Oil in C57BL/6 Mice', Preventive Nutrition and Food Science, 28(4), pp. 411-417. doi:10.3746/pnf.2023.28.4.411 Preclinical
https://doi.org/10.3746/pnf.2023.28.4.411 - Michalska-Ciechanowska, A., Brzezowska, J., Nicolet, N., Haladyn, K. and others (2025) 'Valorization of Rosehip (Rosa canina L.) Pomace Using Unconventional Carbohydrate Carriers for Beverage Obtainment', Molecules, 30(1), pp. 141. doi:10.3390/molecules30010141 Preclinical
https://doi.org/10.3390/molecules30010141 - Vlaicu, P.A., Untea, A.E., Turcu, R.P., Panaite, T.D. and Saracila, M (2022) 'Rosehip (Rosa canina L.) Meal as a Natural Antioxidant on Lipid and Protein Quality and Shelf-Life of Polyunsaturated Fatty Acids Enriched Eggs', Antioxidants (Basel), 11(10), pp. 1948. doi:10.3390/antiox11101948 Preclinical
https://doi.org/10.3390/antiox11101948 - Phetcharat, L. and Wongsuphasawat, K. and Winther, K (2015) 'The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity', Clinical Interventions in Aging, 10, pp. 1849--1856. doi:10.2147/CIA.S90092 Randomized trial
https://doi.org/10.2147/CIA.S90092 - Golsorkhi, H. and Montazerlotfelahi, H. and Abniki, E. and Vafaee-Shahi, M. and Kamalinejad, M. and Qorbani, M. and Bahrami, M. and Dadmehr, M (2025) 'Efficacy and safety of Rosa canina L. and a traditional polyherbal formulation syrup in children and adolescents with attention-deficit/hyperactivity disorder: a factorial randomized double-blind placebo-controlled clinical trial', Phytotherapy Research, 39(9), pp. 4116--4125. doi:10.1002/ptr.70061 Randomized trial
https://doi.org/10.1002/ptr.70061 - Miljkovi\'c, V. M. and Nikoli\'c, L. and Mrmo\v sanin, J. and Gaji\'c, I. and Mihajilov-Krstev, T. and Zvezdanovi\'c, J. and Miljkovi\'c, M (2024) 'Chemical profile and antioxidant and antimicrobial activity of Rosa canina L. dried fruit commercially available in Serbia', International Journal of Molecular Sciences, 25(5), pp. 2518. doi:10.3390/ijms25052518 Preclinical
https://doi.org/10.3390/ijms25052518 - Polumackanycz, M. and Kaszuba, M. and Konopacka, A. and Marzec-Wr\'oblewska, U. and Wesolowski, M. and Waleron, K. and Buci\'nski, A. and Viapiana, A (2020) 'Phenolic composition and biological properties of wild and commercial dog rose (Rosa canina L.) fruits and leaves', Molecules, 25(22), pp. 5272. doi:10.3390/molecules25225272 Preclinical
https://doi.org/10.3390/molecules25225272 - Grajzer, M. and Prescha, A. and Korzonek, K. and Wojakowska, A. and Dziadas, M. and Kulma, A. and Grajeta, H (2015) 'Characteristics of rose hip (Rosa canina L.) cold-pressed oil and its oxidative stability studied by the differential scanning calorimetry method', Food Chemistry, 188, pp. 459--466. doi:10.1016/j.foodchem.2015.05.034 Preclinical
https://doi.org/10.1016/j.foodchem.2015.05.034 - Chrubasik, C., Roufogalis, B.D., Müller-Ladner, U. and Chrubasik, S (2008) 'A systematic review on the Rosa canina effect and efficacy profiles', 22(6), pp. 725--733. doi:10.1002/ptr.2400 Meta-analysis / review
https://doi.org/10.1002/ptr.2400 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Wenzig, E. M. and Widowitz, U. and Kunert, O. and Chrubasik, S. and Bucar, F. and Knauder, E. and Bauer, R (2008) 'Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations', Phytomedicine, 15(10), pp. 826--835. doi:10.1016/j.phymed.2008.06.012 Preclinical
https://doi.org/10.1016/j.phymed.2008.06.012 - Winther, K. and Apel, K. and Thamsborg, G (2005) 'A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial', Scandinavian Journal of Rheumatology, 34(4), pp. 302--308. doi:10.1080/03009740510018624 Randomized trial
https://doi.org/10.1080/03009740510018624 - Rein, E. and Kharazmi, A. and Winther, K (2004) 'A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis: a double-blind, placebo-controlled, randomised trial', Phytomedicine, 11(5), pp. 383--391. doi:10.1016/j.phymed.2004.01.001 Randomized trial
https://doi.org/10.1016/j.phymed.2004.01.001 - Ertas, B. and Hazar-Yavuz, A. N. and Topal, F. and Keles-Kaya, R. and Karakus, \"O. and Ozcan, G. S. and Taskin, T. and Cam, M. E (2023) 'Rosa canina L. improves learning and memory-associated cognitive impairment by regulating glucose levels and reducing hippocampal insulin resistance in high-fat diet/streptozotocin-induced diabetic rats', Journal of Ethnopharmacology, 313, pp. 116541. doi:10.1016/j.jep.2023.116541 Preclinical
https://doi.org/10.1016/j.jep.2023.116541 - Seifi, M. and Abbasalizadeh, S. and Mohammad-Alizadeh-Charandabi, S. and Khodaie, L. and Mirghafourvand, M (2017) 'The effect of Rosa (L. Rosa canina) on the incidence of urinary tract infection in the puerperium: a randomized placebo-controlled trial', Phytotherapy Research, 32(1), pp. 76--83. doi:10.1002/ptr.5950 Randomized trial
https://doi.org/10.1002/ptr.5950 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.